Updated Jul 16, 2026
Stafford Kristin has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $46K.
Kristin Stafford is associated with Zymeworks Inc., a biotechnology company focused on developing multifunctional therapeutics. Specific details about her role and contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | NVCR | NovoCure Ltd | A — Grant or award | 11.6K | $0.00 | |
| 2026-06-03 | NVCR | NovoCure Ltd | S — Open-market sale | 2.9K | $15.77 | $46K |
Kristin Stafford is associated with Zymeworks Inc., a biotechnology company focused on developing multifunctional therapeutics. Specific details about her role and contributions to the company are not widely documented.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($46K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Stafford Kristin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.